Rebecca Johnson
Podiatrist · Salina, KSNPI 1841366242
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 82 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Organogenesis Inc. accounts for 63.4% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $507, 4.9 times the $102 reported in 2019.
Across 82 payments — averaging $22.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$1K
- Smith+Nephew$131
- Paratek Pharmaceuticals, Inc.$124
- AbbVie$96
- Averitas Pharma Inc.$56
- Vertex$51
- plus $218 from 7 others
What the payments were for
- Food & beverage$1,847100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 54 | $1,170 |
| Smith+Nephew | 6 | $131 |
| Paratek Pharmaceuticals, Inc. | 3 | $124 |
| AbbVie | 5 | $96 |
| Averitas Pharma Inc. | 2 | $56 |
| Vertex | 2 | $51 |
| Linvatec Corporation | 1 | $42 |
| Solventum Corporation | 2 | $36 |
| Heron Therapeutics, Inc. | 2 | $35 |
| Melinta Therapeutics, LLC | 2 | $33 |
| Osiris Therapeutics Inc. | 1 | $26 |
| IBSA Pharma Inc. | 1 | $24 |
| Integra Lifesciences Corporation | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PURAPLY WOUND MATRIX$118
- Affinity$118
- Apligraf$118
How this compares
$1,847 in reported general payments places this provider in the 65th percentile of 30 podiatrist providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 20 | $2,100 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 61 | $845 |
| Celecoxib | 14 | $796 |
| Doxycycline Hyclate | 51 | $621 |
| Gabapentin | 32 | $353 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $216 |
| Prednisone | 53 | $182 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 20 | $156 |
| Levofloxacin | 19 | $124 |
| Meloxicam | 45 | $91 |
| Terbinafine Hcl | 14 | $79 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Salina
- Michael FrederiksenSalina$167
- David BlanchoGalena$193K
- Jeffrey RoithOverland Park$69K
- Matthew GallianoOverland Park$19K
- Thomas TruongWichita$11K
- Jennifer PhillipsOverland Park$3K
- Nhi leLenexa$3K
- Henry GoppertTopeka$3K
- Nicholas PosgeEl Dorado$3K
- Kirsten PaulsrudHutchinson$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.